Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression. - Wikidata - awgldk - TriplyDB

Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression.

Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression.

http://www.wikidata.org/entity/Q34588606

about

Mirtazapine inhibits tumor growth via immune response and serotonergic system Pancreatic cancer and depression: myth and truth Review of the use of mirtazapine in the treatment of depression.The societal costs of insomnia Systematic review of sleep disorders in cancer patients: can the prevalence of sleep disorders be ascertained?Does effective management of sleep disorders reduce cancer-related fatigue?Intervention of mirtazapine on gemcitabine-induced mild cachexia in nude mice with pancreatic carcinoma xenografts.Mapping of the Insomnia Severity Index and other sleep measures to EuroQol EQ-5D health state utilities.Survivorship: sleep disorders, version 1.2014.Targeting the Psychosexual Challenges Faced by Couples with Breast Cancer: Can Couples Group Psychotherapy Help?Pharmacological management of depression in patients with cancer: practical considerations.Psychopharmacology in cancer.Effect of protriptyline on [Ca2+]i and viability in MG63 human osteosarcoma cells.Treatment options for hyperemesis gravidarum.Central Neuromodulators for Treating Functional GI Disorders: A Primer.Post hoc analysis of pregabalin vs. non-pregabalin treatment in patients with cancer-related neuropathic pain: better pain relief, sleep and physical health.Does use of tetracyclic antidepressant-mirtazapine reduce cancer risk in depression patients?Efficacy and safety of mirtazapine in fibromyalgia syndrome patients: a randomized placebo-controlled pilot study.The Black Book of Psychotropic Dosing and Monitoring.Psychotropic drug dispensing in people with and without cancer in France.The effect of mirtazapine on gastric accommodation, gastric sensitivity to distention, and nutrient tolerance in healthy subjects.Mirtazapine protects against cisplatin-induced oxidative stress and DNA damage in the rat brain.Effects of mirtazapine on sleep disturbance under neuropathic pain-like state.A research study review of effectiveness of treatments for psychiatric conditions common to end-stage cancer patients: needs assessment for future research and an impassioned plea.A Versatile Adaptive Dose-Finding Design Based on Multiple Endpoints

P2860

Q28481311-2EDD51F1-CE03-4CD1-B501-4D9BBDF21866 Q33723495-CEA7AE3F-EB48-4607-B735-496EB6B22526 Q34190102-875AB6D9-07ED-4764-9C34-7095B415AD7A Q34560329-1F92D7A2-F71D-473F-BA77-A6A59DCC9ABD Q35084910-DB33573B-E041-4F4F-9239-94D59036D44B Q35111356-5B405717-0704-4241-9BBD-61580AFB36E0 Q36031360-82B62575-F2DF-4E90-90FC-067FBD26D255 Q36041272-2C8B2E7B-A8D9-4B6E-B694-F2A96A0D8524 Q36630437-9722A04C-E7CB-40FA-9C65-BE27DFA479AA Q36934667-A29207B1-30B2-478E-B010-48FFB6581004 Q38120495-DD4265EA-FA41-4722-B788-9DD6CC3741B9 Q38270608-FBF2EBF0-A4CF-4E82-8CB3-E797F6275B80 Q38735655-C8498A86-31BB-47B1-8C6F-A0B1CB5D20F4 Q39077715-B0C5A960-C2B3-4564-BE1E-FADC59CE38A4 Q39204575-210C1CD8-7BA3-4DF5-AEDE-5B981E295F85 Q39260473-C758CB09-D16A-4117-91CB-25ADE4F30B6F Q39334973-70E78917-8DDC-4FE6-920E-0C40B8E93CC7 Q42602211-424A67C1-5F3C-496B-A53F-F3850E4A82E9 Q47642128-EB0D4CFF-B4DC-49D3-A2D8-CD28868B821E Q48099427-4122DBD4-FC58-47C8-A960-9EC903587967 Q48147155-134EEDED-3001-49B8-B088-BD8091A40BE6 Q48230329-F13EB150-1AE5-40D1-AD72-3C79C29C8129 Q48266184-889BEB75-FFA2-4F17-AE08-6C5BC52EEBA2 Q55021143-0117EE5B-209F-4979-8870-006197CB6250 Q57637735-99F1B056-D7AB-46FA-87CE-854F0B7FE1FF

P2860

Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression.

http://www.wikidata.org/entity/Q34588606

description

2008 nî lūn-bûn

@nan

2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression.

@ast

Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression.

@en

Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression.

@nl

type

label

Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression.

@ast

Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression.

@en

Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression.

@nl

prefLabel

Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression.

@ast

Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression.

@en

Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression.

@nl

P1433

Q34588606-A66349FE-216B-4641-8FB3-93AF1F579F1C

P1476

Q34588606-52060CBC-263A-45A2-9C1C-32B6FA119302

P2093

Q34588606-012E5040-188F-4162-8CDA-D674F0318011

Q34588606-1273ED73-26B0-454F-A87F-C1E8036448E9

Q34588606-2590A813-B073-4789-859D-80A45A221997

Q34588606-25C3944B-0C94-4177-BB39-9436ECBBA08C

Q34588606-3BC8F4B0-D0EC-473C-A7C2-F84726E80AAD

Q34588606-67EDC2A7-FCAC-4D4D-A457-4D3813EED35F

Q34588606-69CB90A1-6A68-49F6-9EEB-A1506D174798

Q34588606-C496A17F-5712-4F04-AA9B-EF6E965E017E

P2860

Q34588606-11C80F8C-48E9-4857-8F68-DC652B764619

Q34588606-2AA41C31-32FD-4836-83CD-CD6FC37BB890

Q34588606-3229D54E-D735-4F3D-B122-1403A220D235

Q34588606-3CEA428C-0D6F-4A39-8D19-257579A00464

Q34588606-3FBF1272-58AE-4F37-AEBC-590F27083E83

Q34588606-417528B4-E35F-4F3C-8726-079E154299EC

Q34588606-49F76AF5-0B53-4975-B0C2-DD57893828C3

Q34588606-4B88695E-6976-4A5D-AD33-911DE2DC02B4

Q34588606-4B984D94-C87C-4B89-B1FD-49E4C8064352

Q34588606-4F48A534-5872-4390-AFFD-6530D8D75BC4

P304

Q34588606-4AC110AE-FD9D-408A-A799-AB5EACF33B3B

P31

Q34588606-1999A2EF-6057-430F-AF2C-49038A27AE1A

P356

Q34588606-E129EA50-3B22-4318-A6A5-17D3283862C9

P433

Q34588606-12311448-A9CE-4A98-A832-DEA7B4AE088E

P478

Q34588606-F9579168-DD79-45AF-A8B1-45492707F009

P577

Q34588606-BBFB3808-8778-4781-B942-BDF70C18D616

P5875

Q34588606-D5957C7E-8000-4EDF-8D80-36BF9FB8DAEE

P698

Q34588606-6A85C504-6F01-4E46-99C9-099EF929C02F

P356

J.1440-1819.2007.01778.X

P1433

Psychiatry and Clinical Neurosciences

P1476

Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression.

@en

P2093

Il-Seon Shin

http://www.w3.org/2001/XMLSchema#string

Jae-Min Kim

http://www.w3.org/2001/XMLSchema#string

Jin-Sang Yoon

http://www.w3.org/2001/XMLSchema#string

Ki-Min Kim

http://www.w3.org/2001/XMLSchema#string

Kyu-Sik Kim

http://www.w3.org/2001/XMLSchema#string

Su-Jin Yang

http://www.w3.org/2001/XMLSchema#string

Sung-Wan Kim

http://www.w3.org/2001/XMLSchema#string

Young-Chul Kim

http://www.w3.org/2001/XMLSchema#string

P2860

The MOS 36-ltem Short-Form Health Survey (SF-36)

Mirtazapine for severe gastroparesis unresponsive to conventional prokinetic treatment

Prevalence of depression in patients with cancer.

Management of symptoms associated with advanced cancer: olanzapine and mirtazapine. A World Health Organization project.

Impaired sleep and rhythms in persons with cancer.

Differences in drug pharmacokinetics between East Asians and Caucasians and the role of genetic polymorphisms.

Cancer pain, fatigue, distress, and insomnia in cancer patients.

The cancer patient with pain: psychiatric complications and their management.

Mirtazapine use in resistant hyperemesis gravidarum: report of three cases and review of the literature.

An open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptoms.

P304

75-83

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1440-1819.2007.01778.X

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P577

2008-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

227629267

http://www.w3.org/2001/XMLSchema#string

P698

18289144

http://www.w3.org/2001/XMLSchema#string